Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of NVP-1203 in Acute Low Back Pain
NCT03341832Phase 2Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Jan 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aceclofenac, eperisone in acute low back pain, sponsored by NVP Healthcare Co., Ltd.. Started Jan 2018; status: completed.
02
Drugs
aceclofenaceperisone
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT03341832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03341832.